Lifting and material handling equipment company Terex (NYSE:TEX) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 4.9% year on year to $1.23 billion. On the other hand, the company’s full-year revenue guidance of $5.4 billion at the midpoint came in 2.2% above analysts’ estimates. Its GAAP profit of $0.31 per share was 28.8% below analysts’ consensus estimates.
Manufacturing services provider Proto Labs (NYSE:PRLB) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 1.3% year on year to $126.2 million. The company expects next quarter’s revenue to be around $128 million, close to analysts’ estimates. Its non-GAAP profit of $0.33 per share was 13.3% above analysts’ consensus estimates.
Health insurance company Cigna (NYSE:CI) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 14.4% year on year to $65.5 billion. Its non-GAAP profit of $6.74 per share was 6.2% above analysts’ consensus estimates.
Healthcare services provider BrightSpring Health Services (NASDAQ:BTSG) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 11.7% year on year to $2.88 billion. The company’s full-year revenue guidance of $12.25 billion at the midpoint came in 2.5% above analysts’ estimates. Its non-GAAP profit of $0.19 per share was significantly above analysts’ consensus estimates.
Modular flooring manufacturer Interface (NASDAQ:TILE) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 2.6% year on year to $297.4 million. The company expects next quarter’s revenue to be around $360 million, close to analysts’ estimates. Its non-GAAP profit of $0.25 per share was 17.5% above analysts’ consensus estimates.
Precision measurement company Mettler-Toledo (NYSE:MTD) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 4.6% year on year to $883.7 million. Its non-GAAP profit of $8.19 per share was 3.9% above analysts’ consensus estimates.
Industrial manufacturing company Ingersoll Rand (NYSE:IR) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 2.8% year on year to $1.72 billion. Its non-GAAP profit of $0.72 per share was 2.6% below analysts’ consensus estimates.
Healthcare services company Select Medical (NYSE:SEM) missed Wall Street’s revenue expectations in Q1 CY2025 as sales rose 2.4% year on year to $1.35 billion. The company’s full-year revenue guidance of $5.4 billion at the midpoint came in 1.6% below analysts’ estimates. Its GAAP profit of $0.44 per share was 7.3% below analysts’ consensus estimates.
Capstone Holding Corp. expects to reach $100 million revenue and $10 million EBITDA by 2025 through organic growth and acquisitions, with a focus on favorable deal valuations and minimizing dilution. They have secured a flexible equity line of credit and are pursuing both tuck-ins and new platforms to quickly scale amid high housing demand. CAPS shares surged 82.53% premarket on Friday.
Infrastructure construction company MasTec (NYSE:MTZ) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 6% year on year to $2.85 billion. The company expects next quarter’s revenue to be around $3.4 billion, close to analysts’ estimates. Its non-GAAP profit of $0.51 per share was 50% above analysts’ consensus estimates.
Internet, cable TV, and phone provider Cable One (NYSE:CABO) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 5.9% year on year to $380.6 million. Its non-GAAP profit of $12.58 per share was 3.1% above analysts’ consensus estimates.
Bitcoin (CRYPTO: BTC) may be approaching a critical inflection point that could spark a wave of strength across the altcoin market, according to a prominent crypt
